Capricor Therapeutics Inc Investor Relations Material
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders
Latest company events
Ticker symbol
CAPR
Country
United States of America
About the company
Investor Relations Page
Dig deeper into the Capricor Therapeutics Inc fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
